ÃéÀå¾Ï Á¤¹ÐÀÇ·á ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Ä¡·á Á¢±Ù¹ýº°, Áø´Ü ±â¼úº°, Áö¿ªº°, ºÎ¹® µ¿Çâ(2025-2030³â)
Pancreatic Cancer Precision Medicine Market Size, Share & Trends Analysis Report By Therapeutic Approach (Targeted Therapy, Immunotherapy, Chemotherapy-precision Combinations), By Diagnostic Technology, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1679377
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 100 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÃéÀå¾Ï Á¤¹ÐÀÇ·á ½ÃÀåÀÇ ¼ºÀå ¹× µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ ÃéÀå¾Ï Á¤¹ÐÀÇ·á ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 18¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í, ¿¹Ãø ±â°£ µ¿¾È CAGR 19.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ÃéÀå¾Ï Á¤¹Ð ÀÇÇÐ »ê¾÷Àº »ýÁ¸À²À» ³ôÀÌ°í ºÎÀÛ¿ëÀ» ÃÖ¼ÒÈ­Çϴ ǥÀû Ä¡·á¹ý°ú ¸é¿ª ¿ä¹ýÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼ºÀåÀ» °æÇèÇϰí ÀÖ½À´Ï´Ù. ¾×ü »ý°Ë°ú ºÐÀÚ ÇÁ·ÎÆÄÀϸµÀ» Æ÷ÇÔÇÑ Ã·´Ü Áø´Ü µµ±¸´Â Á¶±â ¹ß°ß°ú Ä¡·á È¿°ú¸¦ °³¼±Çß½À´Ï´Ù. ÀÌ·¯ÇÑ Á¤¹Ð ÀÇÇÐÀ¸·ÎÀÇ ÀüȯÀº º¸´Ù È¿°úÀûÀÌ°í °³º°È­µÈ Ä¡·á Àü·«À» °¡´ÉÇÏ°Ô Çß½À´Ï´Ù.

ƯÈ÷ Â÷¼¼´ë ½ÃÄö½Ì°ú »ý¹°Á¤º¸ÇÐÀÇ ÅëÇÕ°ú °°Àº ±â¼ú ¹ßÀüÀº »õ·Î¿î Ä¡·á Ç¥ÀûÀÇ ¹ß°ßÀ» ÃËÁøÇÏ¿© º¸´Ù È¿°úÀûÀÎ ¾à¹° ¼³°è¸¦ °¡´ÉÇÏ°Ô Çß½À´Ï´Ù. Á¦¾à ȸ»ç, Çмú ±â°ü, Á¤ºÎ ±â°üÀº ÅõÀÚ¸¦ ´Ã·Á Çõ½ÅÀûÀÎ Ä¡·á¹ý °³¹ßÀ» Áö¿øÇß½À´Ï´Ù. PanCAN º¸Á¶±Ý ÇÁ·Î±×·¥°ú °°Àº ÀÌ´Ï¼ÅÆ¼ºê´Â ÃéÀå¾Ï ¿¬±¸¿¡ ÀÚ±ÝÀ» Áö¿øÇÏ¿© ½ÃÀå ¼ºÀåÀ» À̲ø¾ú½À´Ï´Ù.

»ýȰ ½À°ü ¿äÀΰú Àα¸ °í·ÉÈ­ÀÇ ¿µÇâÀ¸·Î ÃéÀå¾Ï ¹ßº´·üÀÌ Áõ°¡Çϸ鼭 Àü¹® Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁ³½À´Ï´Ù. 2024³â È£ÁÖ¾ÏÇùȸ´Â È£ÁÖ¿¡¼­ 4,641°ÇÀÇ »õ·Î¿î ÃéÀå¾ÏÀÌ Áø´ÜµÉ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù. ÀÌ·¯ÇÑ À¯º´·ü Áõ°¡´Â ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀÌ º¸´Ù È¿°úÀûÀÎ ¿É¼ÇÀ» ¸ð»öÇϸ鼭 ½ÃÀå ¼ºÀåÀ» ÃËÁøÇß½À´Ï´Ù. ¶ÇÇÑ Á¦¾àȸ»ç¿Í ¿¬±¸ ±â°ü °£ÀÇ Àü·«Àû Çù¾÷°ú ±ÔÁ¦ Áö¿øÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­Çß½À´Ï´Ù.

ÃéÀå¾Ï Á¤¹ÐÀÇ·á ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÃéÀå¾Ï Á¤¹ÐÀÇ·á ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ÃéÀå¾Ï Á¤¹ÐÀÇ·á ½ÃÀå : Ä¡·á Á¢±Ù¹ýº° »ç¾÷ ºÐ¼®

Á¦5Àå ÃéÀå¾Ï Á¤¹ÐÀÇ·á ½ÃÀå : Áø´Ü ±â¼úº° ºñÁî´Ï½º ºÐ¼®

Á¦6Àå ÃéÀå¾Ï Á¤¹ÐÀÇ·á ½ÃÀå : Áö¿ªº°, ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦7Àå °æÀï ±¸µµ

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Pancreatic Cancer Precision Medicine Market Growth & Trends:

The global pancreatic cancer precision medicine market size is anticipated to reach USD 1.88 billion by 2030, registering a CAGR of 19.2% during the forecast period, according to a new report by Grand View Research, Inc. The pancreatic cancer precision medicine industry experiences growth due to the increasing adoption of targeted therapies and immunotherapies, which enhanced survival rates and minimized side effects. Advanced diagnostic tools, including liquid biopsies and molecular profiling, improved early detection and treatment efficacy. This shift towards precision medicine facilitated more effective, individualized treatment strategies.

Technological progress, specifically the integration of next-generation sequencing and bioinformatics, facilitated the discovery of new therapeutic targets, enabling more effective drug design. Pharmaceutical companies, academic institutions, and government organizations increased their investments, supporting the development of innovative therapies. Initiatives such as the PanCAN grants program demonstrated a commitment to funding pancreatic cancer research, driving market growth.

The rising incidence of pancreatic cancer, influenced by lifestyle factors and an aging population, created a higher demand for specialized treatments. In 2024, Cancer Australia estimated 4,641 new pancreatic cancer cases were diagnosed in the country. This growing prevalence propelled market growth as healthcare providers sought more effective options. Furthermore, strategic collaborations between pharmaceutical companies and research institutions and regulatory support further accelerated market growth.

Pancreatic Cancer Precision Medicine Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Pancreatic Cancer Precision Medicine Market Variables, Trends, & Scope

Chapter 4. Pancreatic Cancer Precision Medicine Market: Therapeutic Approach Business Analysis

Chapter 5. Pancreatic Cancer Precision Medicine Market: Diagnostic Technology Business Analysis

Chapter 6. Pancreatic Cancer Precision Medicine Market: Regional Estimates & Trend Analysis

Chapter 7. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â